Close
Muscle Study Group Annual Meeting
16-18 September 2013 at Lady Margaret Hall, Oxford
The 2013 meeting was entitled "Novel Molecular Mechanisms of Neuromuscular Disease: Implications for Therapy", and brought together members of the pharmaceutical industry, NIH and academic researchers.
The programme included four major sessions:
1. Novel Molecular Mechanisms:
Implications for Therapy Development - Hereditary Myopathies
2. Overcoming Hurdles of Developing and Performing Clinical Trials
3.
Novel Molecular Mechanisms: Implications for Therapy Development -
Hereditary Neuropathies
4. Disorders of the NMJ: The View from
Oxford
Update in Neuromuscular Disorders
7-10th May 2013 at Queen Square